We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+9.44%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$693M
AUM Growth
+$45.3M
Cap. Flow
-$3.57M
Cap. Flow %
-0.52%
Top 10 Hldgs %
27.41%
Holding
501
New
6
Increased
–
Reduced
6
Closed
14

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2M
2
PPLI
People Inc
PPLI
+$216K
3
VMW
VMware, Inc
VMW
+$207K
4
CCOI icon
Cogent Communications
CCOI
+$196K
5
VSAT icon
Viasat
VSAT
+$194K

Top Sells

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$1.61M
2
APEN
Apollo Endosurgery, Inc.
APEN
+$1.29M
3
MGI
MoneyGram International, Inc. New
MGI
+$1.04M
4
TA
TravelCenters of America LLC
TA
+$865K
5
HSKA
Heska Corp
HSKA
+$683K

Sector Composition

Rank Sector Weight
1 Technology 28.14%
2 Healthcare 14.27%
3 Industrials 11.75%
4 Financials 10.7%
5 Consumer Discretionary 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YELP icon
376
Yelp
YELP
$1.47B
$295K 0.04%
8,100
– –
ZBH icon
377
Zimmer Biomet
ZBH
$18.8B
$291K 0.04%
2,000
– –
NXRT
378
NexPoint Residential Trust
NXRT
$660M
$291K 0.04%
6,400
– –
IDCC icon
379
InterDigital
IDCC
$7.98B
$290K 0.04%
3,000
– –
NTLA icon
380
Intellia Therapeutics
NTLA
$1.5B
$290K 0.04%
7,100
– –
USX
381
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$289K 0.04%
47,000
– –
IR icon
382
Ingersoll Rand
IR
$34.1B
$288K 0.04%
4,412
– –
SIMO icon
383
Silicon Motion
SIMO
$8.53B
$287K 0.04%
4,000
– –
BLKB icon
384
Blackbaud
BLKB
$2.01B
$285K 0.04%
4,000
– –
PARA
385
DELISTED
Paramount Global Class B
PARA
$285K 0.04%
17,887
– –
FIBK icon
386
First Interstate BancSystem
FIBK
$3.75B
$281K 0.04%
11,795
– –
EBIX
387
DELISTED
Ebix Inc
EBIX
$277K 0.04%
11,000
– –
NI icon
388
NiSource
NI
$21.3B
$274K 0.04%
10,000
– –
BAX icon
389
Baxter International
BAX
$14.5B
$273K 0.04%
6,000
– –
ESPR
390
DELISTED
Esperion Therapeutics
ESPR
$271K 0.04%
195,125
– –
CMRE icon
391
Costamare
CMRE
$1.87B
$271K 0.04%
28,000
– –
GIII icon
392
G-III Apparel Group
GIII
$1.54B
$270K 0.04%
14,000
– –
WKC icon
393
World Kinect Corp
WKC
$2B
$269K 0.04%
13,000
– –
CVU icon
394
CPI Aerostructures
CVU
$64.7M
$265K 0.04%
68,000
– –
VERV
395
DELISTED
Verve Therapeutics
VERV
$263K 0.04%
14,000
– –
JBTM
396
JBT Marel
JBTM
$7.41B
$262K 0.04%
2,160
– –
ADC icon
397
Agree Realty
ADC
$9.57B
$262K 0.04%
4,000
– –
KBR icon
398
KBR
KBR
$4.68B
$260K 0.04%
4,000
– –
AMRN
399
Amarin Corp
AMRN
$297M
$259K 0.04%
10,900
– –
KBH icon
400
KB Home
KBH
$3.45B
$259K 0.04%
5,000
– –
14 15
16
17 18

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q2 2023 Portfolio in Review

As of Q2 2023, NJ State Employees Deferred Compensation Plan held 501 positions worth $693M, up 7% from $648M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. NJ State Employees Deferred Compensation Plan opened 6 new positions and exited 14, leaving the 501-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.

  • NJ State Employees Deferred Compensation Plan's largest Q2 2023 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 19,000 shares worth $1.95M.
  • NJ State Employees Deferred Compensation Plan's biggest Q2 2023 reduction was Concentrix, cutting an estimated $88.6K.
  • NJ State Employees Deferred Compensation Plan fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $1.61M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 27% of its $693M portfolio in Q2 2023.
  • NJ State Employees Deferred Compensation Plan opened 6 new positions and closed 14 in Q2 2023.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 7% quarter-over-quarter to $693M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2023, filed 2 Aug 2023.